This document discusses balloon aortic valvuloplasty (BAV) as a treatment for aortic stenosis. It can be performed via either a retrograde or antegrade approach. The retrograde approach involves crossing the aortic valve from the femoral artery, while the antegrade approach involves transseptal catheterization from the femoral vein. Key steps for both approaches include rapid ventricular pacing to stabilize the heart during balloon inflation. The goals of BAV are to increase the aortic valve area and reduce pressure gradients. Complications can include hypotension, aortic regurgitation, and embolization of calcium deposits. BAV provides symptomatic relief but is usually not curative, as restenosis may occur.
Aortic stenosis (AS) is common in older adults. Surgical options include SAVR and BAV, with TAVI for high-risk patients.
Aortic stenosis (AS) is common in older adults. Surgical options include SAVR and BAV, with TAVI for high-risk patients.
Goals of BAV include doubling valve area and symptomatic improvement. BAV relies on mechanisms involving fracturing calcified nodules.
Two approaches: retrograde and antegrade. Steps include patient prep, guidewire use, balloon inflation.Detailed preparation steps include sedation, access setup, and monitoring during valve procedures.
Two approaches: retrograde and antegrade. Steps include patient prep, guidewire use, balloon inflation.
Two approaches: retrograde and antegrade. Steps include patient prep, guidewire use, balloon inflation.
Two approaches: retrograde and antegrade. Steps include patient prep, guidewire use, balloon inflation.
Detailed preparation steps include sedation, access setup, and monitoring during valve procedures. Post-BAV immediate care entails hemostasis and monitoring. Results show improvement in valve area and gradient.
Post-BAV immediate care entails hemostasis and monitoring. Results show improvement in valve area and gradient. Complications in BAV procedures include procedural death and vascular issues. Perspectives on usage are limited.
Complications in BAV procedures include procedural death and vascular issues. Perspectives on usage are limited.
Introduction
Aortic stenosis(AS) is the most common form of adult valvular heart
disease, more prevalent in the aging population.
Surgical Aortic Valve Replacement (SAVR) is the treatment of choice,
only definitive treatment to relieve symptoms or to improve survival.
Despite extensive/exhaustive guidelines and recommendations one
third of patients are not referred to surgery – because of old age,
left ventricular dysfunction and comorbidities.
Balloon Aortic Valvuloplasty (BAV) fills the gap and its successor
Transcatheter Aortic Valve Implantation (TAVI) will be an option for
the surgical high risk patients.
Ideal patient
Palliative procedure
BRIDGETO SURGERY
Frail patients
Extremely old
Compromised clinical status from concomitant CAD and other
extracardiac comorbidities.
8.
Indications for BAVin adults
Cardiogenic shock.
Bridge to aortic valve surgery.
Symptomatic critical AS requiring emergency noncardiac
surgery.
Poor surgical candidate owing to high risk – age > 90 yrs.
Diagnostic testing in low gradient/low output setting
Congenital aortic stenosis
Rheumatic aortic stenosis
Predilatation before TAVI
Goals
A 100%increase in the aortic valve area.
Symptomatic improvement
12.
Maximum pressureexerted on the valve leaflets during balloon
inflation.
Proper balloon sizing.
Optimal contact with the valve structures.
Final valve area is a determinant of the prognosis.
13.
Why BAV isnot successful as that of PBMV?
The results of BAV are limited by the pathology involved in the
disease.
Degenerative AS is MC etiology.
Chronic inflammatory process.
Commissural fusion is not the predominant feature in majority of
older patients with calcific AS.
Fracture of nodular calcium deposits – leaflet mobility improved –
increased valve opening – blood flow increased during LV
contraction.
14.
MECHANISMS OF ACTION
Theeffects of BAV on stenosed aortic valves are poorly understood, but
several mechanisms appear likely.
• Primarily, balloon-induced fracturing of calcified nodules creates
hinge points, which along with the creation of cleavage planes in
collagenous stroma, results in improved leaflet flexibility and valve
opening.
• Separation of fused leaflets is uncommon given its infrequent
occurrence in this patient population with calcific aortic stenosis.
• Enhanced compliance or stretching of the adjacent annulus and
calcified aortic root has also been suggested.
15.
When maximally inflated,a 20-mm diameter balloon (occupying a 3.14 cm2 cross-sectional area)
significantly enlarges the stenosed valve orifice by 3 mechanisms:
stretching of valve tissue,
rupturing of commissural fusion and
breaking of calcific deposits.
These last 2 mechanisms are the most effective, in both tricuspid and bicuspid forms of AS,
to render the cusps more flexible .
Stretching alone may give only a temporary increase in valve area with an elastic return of the leafle
to their initial stenosing position and may explain, at least in part, the occurrence of restenosis.
Inflation of the balloon is well tolerated with no deleterious decrease in blood pressure in two-thirds
of the cases because the balloon opens the commissures, allowing blood ejection through these
openings.
It does not produce calcific emboli, probably because calcium deposits remain imbedded in the
leaflets, covered by the endothelium.
Finally, it very infrequently produces acute severe aortic regurgitation.
Careful choice of balloon size is necessary to obtain on effective opening; most often a 20-mm
diameter balloon but sometimes a balloon up to 23 mm is used.
Am J Cardiol. 1988 Dec 1;62(17):1241-7
http://www.ncbi.nlm.nih.gov/pubmed/3195485
The Retrograde approach
First described by Lababidi in infants and children.
Alain Cribier et al in adults.
Procedure time < 1 hr.
Less complications
Dr.Zuhdi Lababidi
18.
Steps in theprocedure
Patient preparation.
Equipments – guidewires,sheath,balloon catheters.
Retrograde crossing of the native aortic valve.
Rapid ventricular pacing (RVP)
Balloon inflation.
Simultaneous gradients across the aortic valve
Hemostasis.
19.
Patient preparation
Mildsedation with IV midazolam, local anaesthesia.
Femoral arterial and venous access – 8F sheath.
UFH 3000-5000IU IV at start of procedure.
Coronary angiography in the same sitting, if needed coronary
intervention will also be done after BAV.
Right heart catheterization – Swan Ganz thermodilution catheter.
For TAVI – Supraaortic angiography – shallow LAO, followed by
abdominal and pelvic angiography.
20.
Guidewire
Extra stiffAmplatz 0.035”, 270 cm length guidewire
(Cook,Bjaeverskov,Denmark)
All catheter exchanges.
Stabilizing the valvuloplasty balloon during
Inflation.
Deflation
Withdrawal
Large pigtail shaped curve is formed at the distal end of the wire with
a dull instrument to prevent ventricular perforation and to decrease
ectopy.
22.
Sheaths
8F arterialsheath is replaced over the extrastiff wire with a 10F,12F or
14F sheath, depending on the balloon catheter required.
Reduction in the profile of the devices – reduces local complications at
the femoral artery puncture site.
12-14 F sheaths – hemostasis by preclosing with a 10F Prostar device
(Prostar, Abbott Vascular, Redwood City,Ca).
10 F sheath – 8F angioseal device (Angioseal Vascular closure
device,St Jude Medical,Belgium) at the end of the procedure.
23.
Balloon catheters
Tyshakballoon – retrograde technique
Inoue balloon – antegrade technique
Double balloon technique – antegrade
Catheters /Balloons Sheath size/
length of balloons
Double sized Cribier Letac catheters. 12-14 F
Z med II balloon catheter (Numed Inc.,Hokinton NY, USA). 12-14 F
Cristal balloons (Balt Extrusion,Montmorency,France) 10 F
23 mm diameter balloons(usually used) 45 mm
25 mm diameter balloon 50 mm
20 mm diameter balloon (if < 19 mm on echocardiography,
densely calcified)
45 mm
25 mm diameter balloon (if aortic annulus diameter is >24 mm, 25% cases)
24.
Retrograde crossing ofthe aortic valve
AL -2 commonly used.
Dual multilumen or pigtail catheter – peripheral augmentation is absent.
Straight tip, fixed core ,0.035” guide wire.
40LAO – catheter positioned at the rim of the valve.
Catheter is slowly pulled back, firm clockwise rotation maintained to direct
the catheter tip toward the centre of the valve plane.
Guidewire is carefully moved in and out of the catheter tip, sequentially
mapping the valve surface and exploring the valve orifice.
Once as the wire crosses, the catheter positioned at the middle of LV.
Transvalvular gradient is obtained from the side arm of the femoral sheath.
Cardiac output measured.
Aortic valve area by Gorlin’s equation.
26.
Rapid ventricular pacing(RVP)
6F temporary bipolar pacing lead – RV posterior wall
Pulse generator – 200 to 220 beats/min
Effective pacing is – precipitous fall in blood pressure to at least 50 mm Hg.
Initial 200/min – no response – increase to 220/min
If 2:1 block is seen,rate is reduced to 180 beats/min or modify the lead position.
Demand mode at 80 /min - in case of VAGAL response, AV conduction interruption leading to
bradycardia or asystole in repsonse to balloon inflation.
In the past, before the use of RVP, always challenging to maintain the balloon in the optimal
position during balloon inflation.
27.
Figure 3. Rapidventricular pacing stabilises the balloon when it is inflated. A pacing catheter is
placed in the right ventricle. Rapid ventricular pacing is initiated at approximately 180–220 bpm
and temporarily leads to a drop in systemic pressure. The balloon is inflated only after the pacing
rate is reached and the blood pressure drops, and pacing is also continued until the balloon is
deflated
29.
Contrast solution
Shortextension tubing with a three way stop cock attached is
connected to a hand held 30 ml leur lock syringe filled with diluted
contrast.
Contrast dilution at 15% contrast to 85% saline – reduces viscosity
- facilitates inflation, deflation cycles.
30.
Further steps inBAV
Diagnostic catheter is removed from the LV over the extrastiff wire
Looped flexible segment of wire is carefully maintained in the LV
cavity.
8F sheath is replaced by the 10F sheath over the extra stiff wire.
After flushing the distal lumen and applying negative pressure on the
balloon port, the balloon catheter is mounted on the extra stiff wire.
The system advanced into the aorta and allowed to rest above the
aortic valve.
Partial inflation and then completely deflated one or more times to
completely purge it of air bubbles.
31.
Cont…
De airingof the balloon in the ascending aorta – lowest balloon profile
while crossing the aortic arch – decreasing the risk of atheromatous
plaque dislodgement and embolization.
Balloon catheter is advanced across the aortic valve centering the
valve between two markers.
The inflated balloon would tend to pop into the LV abruptly, striking
the apex,or would “eject” itself back into the aorta with the possibility
of disrupting atheromatous plaque,which would embolize.
32.
Balloon inflation
Clearcommunication between the operators manipulating the balloon
catheter and the pacing device.
RVP and simultaneous forward pressure on the balloon catheter and forward
pressure on the extra stiff wire help stabilize the balloon during inflation.
Traction on the guidewire causes forward movement on the balloon.
Pushing the guidewire displaces the balloon in the aortic direction
allowing for better positioning.
RVP turned on, balloon inflation is started quickly and with enough pressure
to rapidly inflated the balloon as soon as the blood pressure falls.
RVP continued for few seconds after the balloon reaches the maximum
inflation.
Balloon is rapidly deflated, pacer is turned off, the balloon withdrawn from
the valve – clear coordination is required to allow restoration of antegrade
flow while maintaining safe wire position in LV.
33.
Figure 1. Balloonaortic valvuloplasty (BAV) via the retrograde approach. After correctly
positioning across the stenotic valve the balloon is inflated with dilute contrast material. Note the
temporary pacing wire in the right ventricle and the pigtail shaping of the left ventricular wire
35.
Rapid balloondeflation and restoration of blood flow were important
to minimize the time of hypoperfusion and hypotension.
Allow time for heart and BP to return to preinflated parameters before
proceeding to inflate the balloon again.
Observe the wave form of the aortic pressure tracing, as well as heart
rate response, rhythm and BP recovery.
A sudden change in waveform with loss of dicrotic notch or falling
diastolic pressure could indicate the presence of severe AR.
Improvement of the pressure slope is suggestive of successful
procedure.
36.
Particular caremust be taken as the deflated balloon is drawn
through the sheath.
If resistance encountered, remove the catheter and sheath as a
single unit.
Residual gradient – simultaneous measurement of pressure in the
LV and in the aorta.
Significant gradient – next larger balloon may be chosen and the
sequence is repeated.
37.
Final steps
Pullback gradient is obtained after the final balloon inflation.
Remove the pacemaker.
Cardiac output is measured.
Final aortic valve area is calculated.
Supraaortic angiography – for presence and severity of AR.
If contrast not used,assessment can be by TTE.
38.
Figure 2. Aorticand left ventricular traces pre- and post-valvuloplasty. The mean aortic pressure
gradient has reduced significantly from 50 mmHg to 25 mmHg
39.
Optimal result
Doublingof the valve area.
Decreasing the gradient by 50% compared with the baseline value.
40.
Immediate management afterBAV
Manual compression is used for hemostasis at the venous entry site.
Arterial hemostasis is achieved with closure device.
Pneumatic pressure device in case of technical failure.
Uncomplicated cases – discharge in 2 days.
In case of severe CHF or cardiogenic shock – monitoring in ICU with
inotropic support is required.
MC cause of hypotension – vagal reactions.
Pericardial tamponade or retroperitoneal bleed not to be forgotten.
Patient preparation
MildIV sedation and local anaesthesia.
Femoral venous access bilaterally obtained – 8F sheath in Rt. femoral
vein and 6F sheath in Lt. femoral vein.
Coronary angiography through 6F sheath – brachial(or radial) artery.
Pigtail placed above the aortic valve.
Right heart catheterization and baseline hemodynamics measurements
are recorded.
Left femoral vein access, bipolar pacing catheter –RV apex.
RVP as needed.
44.
Trans septal catheterization
8F Mullins sheath.
Brockenbrough needle via the right femoral vein.
Crossing the septum – left lateral view.
A pigtail catheter is positioned in the ascending aorta through out the
procedure for monitoring the blood pressure, as a reference marker for the
trans septal puncture.
Middle third of a virtual line connecting the distal tip of the pigtail catheter
adjacent to the aortic calcification and the posterior border of the heart.
After entry into LA is confirmed, then UFH 5000 IU is administered IV.
7F Swan Ganz catheter which has an inner lumen compatible with a 0.035
inch guidewire across the mitral valve into the LV Under fluoroscopic
guidance - 40 RAO projection.
Trans aortic gradient - Swan Ganz in LV and pigtail in aorta.
Aortic valve area calculated by Gorlin’s equation.
45.
Crossing the aorticvalve
Mullins sheath is advanced approx. 2cm beyond the mitral valve.
Balloon of the Swan Ganz catheter is inflated and directed into the
LVOT approaching the native aortic valve.
A 0.035’’ straight wire may facilitate crossing the aortic valve with the
balloon deflated, as the catheter pushed over the wire into the
ascending aorta.
Wire is removed, and the balloon is reinflated.
Catheter is advanced into the descending aorta and positioned at the
level of the distal aortic bifurcation with an Amplatz 0.035” ,360 cm
long extrastiff guidewire.
Balloon is deflated and the catheter is removed.
46.
The “essential” guidewireloop in the left
ventricle
Large loop in the guidewire to be kept in the left ventricle.
Straightening of the guidewire between the mitral valve and the aortic
valve can keep the mitral valve open, resulting in severe mitral
regurgitation with hemodynamic deterioration.
Loop within the left ventricle is maintained with continuous
monitoring at each step of the procedure.
8F sheath is replaced with a 10 F sheath for the subsequent balloon
dilatation using the cristal balloon catheter (12F or 14F if NuMed
balloons are used).
47.
Atrial septostomy
Theatrial septum is dilated with an 8mm diameter balloon septostomy
catheter through the 10 F sheath in the right femoral vein.
Diluted solution of contrast media:saline (15:85) is used with a 10 ml
syringe for atleast two balloon inflations of 30 seconds each.
48.
Antegrade Balloon AorticValvuloplasty
Same balloon catheters are used as for retrograde approach.
Dilatation of the aortic valve is done preferentially with the 23 mm
diameter balloon, which is advanced through the 10 F sheath and
positioned across the aortic valve, while the loop is maintained in the
LV.
Same steps as in retrograde technique.
Not feasible to measure the gradient after inflations of each diameter
of balloon with this technique.
Aortic pressure waveform for the hemodynamic result.
50.
If asignificant fall in diastolic pressure does not occur, then the next
larger balloon size can be chosen.
When two or three inflations using the largest selected balloon size are
completed, the balloon catheter is removed.
A 6F pigtail catheter is advanced over the extrastiff wire and
positioned over the arch so that the wire can be removed shielded by
the catheter, thus avoiding injury to the aorta or the mitral valve.
51.
Final gradient– pigtail in the LV and other catheter in the aorta.
Supra aortic angiogram can be obtained.
Pacing catheter can be removed if there is no AV conduction defect.
Swan Ganz catheter for the final hemodynamic results.
Hemotasis is obtained by manual compression over the artery and the
vein after sheath removal.
Bed rest for 24 hours.
ICU monitoring required for patients who presented in caridogenic
shock.
52.
Results using contemporaryBAV techniques.
141 consecutive patients
Severe Aortic stenosis – high risk for surgery or inoperable
January 2002 to April 2005
Average age was 80.3±10 years.
45 % were women
NYHA IV -80%
LVEF < 30% - 28%
Emergency procedure in cardiogenic shock – 5.6% cases
Retrograde approach in 95% of the cases.
Largest balloon used was 23 mm balloon size – 84% of the procedures.
Agatiello C,Eltchaninoff H et al.Arch Mal Coeur 99;195-200:2006.
53.
Results
Immediate results
Increase inaortic valve area from 0.59± 0.19 to 1.02± 0.34 cm² (p<0.001)
Decrease in transvalvular gradient from 49.3± 21.2 to 22.2± 11.8 mm Hg (p<0.001)
Post BAV AR grade 2 – 14%, grade 3 – 3.5%,grade 4 1.4 % cases.
Death – 6 patients (4%)
Nonfatal severe complications – 9 patients (6%) - 2 transient strokes,5 complete AV block,2
severe AR.
Vascular complications – 8,no surgical repair.
Discharge from the hospital was at 5.6± 3 days.
Clinically apparent neurological deficit - < 2%.
Embolization of atheromatous debris – rare.
Agatiello C,Eltchaninoff H et al. Arch Mal Coeur 99;195-200:2006.
54.
Comparisons of complicationrates in the Rouen
Series and in the Mansfield Registry
Complications Mansfield Scientific Aortic
Valvuloplasty Registry
1986-1988
(N=492)
Rouen Series
2002-2005
(N=141)
Procedural death 2(4.9%) 3 (2.1%)
Post procedural death (<7 days) 12(2.6%) 3(2.1%)
Cerebral embolic events 11(2.2%) 2(1.4%)
Transient ischemic attacks 5(1.1%) 0(0%)
Ventricular perforation with
tamponade
11(2.2%) 0(0%)
Severe AR 5(1.1%) 2(1.4%)
Vascular complications (surgical
repair)
27(5.5%) 0(0%)
Non fatal arrhythmias 5(1.1%) 5(3.5%)
MI,sepsis,renal failure 8(1.6%) 1(1%)
56.
Non calcific aorticstenosis
Predominantly fibrotic – well suited for BAV.
Procedure effective in 80-90% cases.
Mortality rate of approx. 0.7%.
Survival at 8 yrs - 95%
Need for repeat intervention of 25% at 4yrs and 50% at 8 yrs.
Rosenfeld et al –
no deaths,no embolic events.
Intermediate follow up at 38 months - 50% patients required no
further intervention.
58.
Current perspectives ofBAV
No Class I or IIA Recommendations for BAV.
Class II B Recommendations for adult patients with severe AS are
1.hemodynamic unstable patients, candidates for bridge to surgery.
2.as a palliative procedure for patients with severe comorbid
conditions which would preclude AVR.
3.criticalsymptomatic AS
4.contributing role of AS to dyspnea in patients with severe lung
disease.
5.to assess myocardial contractile reserve in patients with lowgradient
or low EF.